Novel drug discovery strategies for the treatment of decompensated cirrhosis

Keyphrases

• Acute-on-chronic Liver Failure 66%
• Area Cover 33%
• Cardiovascular Dysfunction 33%
• Cirrhosis 33%
• Cirrhosis-related Complications 33%
• Clinical Heterogeneity 33%
• Combinational Therapy 33%
• Computational Drug Discovery 100%
• Curative Treatment 33%
• Decompensated Cirrhosis 100%
• Disease Course 66%
• Disease Progression 33%
• Drug Discovery 33%
• Drug pipeline 100%
• End-stage Liver Disease 100%
• Expert Opinion 33%
• High Demand 33%
• High Mortality 33%
• Improved Patient Outcomes 33%
• Liver 33%
• Metabolic Dysfunction 33%
• Organ Failure 66%
• Organ Scarcity 33%
• Organ Support 33%
• Pathomechanism 33%
• Portal Hypertension 33%
• Precipitating Event 33%
• System Inflammation 33%
• Therapeutic Strategies 33%
• Tissue Injury 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Acute on Chronic Liver Failure 66%
• Decompensated Liver Cirrhosis 100%
• Disease Course 66%
• Disease Exacerbation 33%
• Drug Discovery 100%
• End Stage Liver Disease 100%
• Inflammation 33%
• Liver Cirrhosis 66%
• Portal Hypertension 33%
• Tissue Injury 33%